Medical Management of Cerebral Edema
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Driving Cerebral Perfusion Pressure with Pressors: How, Which, When?
Driving Cerebral Perfusion Pressure with Pressors: How, Which, When? J. A. MYBURGH Department of Intensive Care Medicine, The St George Hospital, Sydney, NEW SOUTH WALES ABSTRACT In traumatic brain injury, cerebral hypoperfusion is associated with adverse outcome, particularly in the early phases of management. This has resulted in the increased use of drugs such as adrenaline, noradrenaline, dopamine and phenylephrine to augment or maintain systemic blood pressures at near normal levels. This is now part of standard practice and is endorsed by the Brain Trauma Foundation guidelines. It probably matters little which agent is used, provided appropriate monitoring is in place and those reversible causes of hypotension are promptly excluded and treated. However, blindly applying management guidelines to all patients may negate these early benefits. The time has come move away from artificially separated concepts of “intracranial pressure” versus “cerebral perfusion pressure” based strategies. These should be considered in parallel and applied to an individual patient, rather than making the patient fit into an all-encompassing treatment algorithm. A paradigm shift from a “set and forget” philosophy to one of “titration against time” to achieve appropriate therapeutic targets is now required. In this context the rational use of vasoactive agents to optimise cerebral perfusion pressure may be employed. On the basis of limited animal and human evidence, noradrenaline appears to be the most appropriate catecholamine for traumatic brain injury, although definitive, targeted trials are required. (Critical Care and Resuscitation 2005; 7: 200-205) Key words: Cerebral perfusion, inotropic agents, resuscitation, head injury, review The recognition of the importance of defending simplistic. -
DIAGNOSTICS and THERAPY of INCREASED INTRACRANIAL PRESSURE in ISCHEMIC STROKE
DIAGNOSTICS and THERAPY of INCREASED INTRACRANIAL PRESSURE in ISCHEMIC STROKE Erich Schmutzhard INNSBRUCK, AUSTRIA e - mail: erich.schmutzhard@i - med.ac.at Neuro - ICU Innsbruck Conflict of interest : Speaker‘s honoraria from ZOLL Medical and Honoraria for manuscripts from Pfizer Neuro - ICU Innsbruck OUTLINE Introduction Definition: ICP, CPP, PbtiO2, metabolic monitoring, lactate , pyruvate , brain temperature etc Epidemiology of ischemic stroke and ICP elevation in ischemic stroke ACM infarction and the role of collaterals and/ or lack of collaterals for ICP etc Hydrocephalus in posterioir fossa ( mainly cerebellar ) infarction Diagnosis of ICP etc Monitoring of ICP etc Therapeutic management : decompressive craniectomy – meta - analysis of DESTINY HAMLET und co deepening of analgosedation , ventilation , hyperventilation , osmotherapy , CPP - oriented th , MAP management , hypothermia , prophylactic normothermia , external ventricular drainage Neuro - ICU Innsbruck Introduction - Malignant cerebral edema following ischemic stroke is life threatening. - The pathophysiology of brain edema involves failure of the sodium - potassium adenosine triphosphatase pump and disruption of the blood - brain barrier, leading to cytotoxic edema and cellular death. - The Monro - Kellie doctrine clearlc states that - since the brain is encased in a finite space - increased intracranial pressure (ICP) due to cerebral edema can result in herniation through the foramen magnum and openings formed by the falx and tentorium. - Moreover, elevated ICP can cause secondary brain ischemia through decreased cerebral perfusion and blood flow, brain tissue hypoxia, and metabolic crisis. - Direct cerebrovascular compression caused by brain tissue shifting can lead to secondary infarction, especially in the territories of the anterior and posterior cerebral artery. - Tissue shifts can also stretch and tear cerebral vessels, causing intracranial hemorrhage such as Duret’s hemorrhage of the brainstem. -
Stroke Intracranial Hypertension Cerebral Edema Roman Gardlík, MD, Phd
Stroke Intracranial hypertension Cerebral edema Roman Gardlík, MD, PhD. Institute of Pathological Physiology Institute of Molecular Biomedicine [email protected] Books • Silbernagl 356 • Other book 667 Brain • The most complex structure in the body • Anatomically • Functionally • Signals to and from various part of the body are controlled by very specific areas within the brain • Brain is more vulnerable to focal lesions than other organs • Renal infarct does not have a significant effect on kidney function • Brain infarct of the same size can produce complete paralysis on one side of the body Brain • 2% of body weight • Receives 1/6 of resting cardiac output • 20% of oxygen consumption Blood-brain barrier Mechanisms of brain injury • Various causes: • trauma • tumors • stroke • metabolic dysbalance • Common pathways of injury: • Hypoxia • Ischemia • Cerebral edema • Increased intracranial pressure Hypoxia • Deprivation of oxygen with maintained blood flow • Causes: • Exposure to reduced atmospheric pressure • Carbon monoxide poisoning • Severe anemia • Failure to ogygenate blood • Well tolerated, particularly if chronic • Neurons capable of anaerobic metabolism • Euphoria, listlessness, drowsiness, impaired problem solving • Acute and severe hypoxia – unconsciousness and convulsions • Brain anoxia can result to cardiac arrest Ischemia • Reduced blood flow • Focal / global ischemia • Energy sources (glucose and glycogen) are exhausted in 2 to 4 minutes • Cellular ATP stores are depleted in 4 to 5 minutes • 50% - 75% of energy is -
Idiopathic Intracranial Hypertension
IDIOPATHIC INTRACRANIAL HYPERTENSION William L Hills, MD Neuro-ophthalmology Oregon Neurology Associates Affiliated Assistant Professor Ophthalmology and Neurology Casey Eye Institute, OHSU No disclosures CASE - 19 YO WOMAN WITH HEADACHES X 3 MONTHS Headaches frontal PMHx: obesity Worse lying down Meds: takes ibuprofen for headaches Wake from sleep Pulsatile tinnitus x 1 month. Vision blacks out transiently when she bends over or sits down EXAMINATION Vision: 20/20 R eye, 20/25 L eye. Neuro: PERRL, no APD, EOMI, VF full to confrontation. Dilated fundoscopic exam: 360 degree blurring of disc margins in both eyes, absent SVP. Formal visual field testing: Enlargement of the blind spot, generalized constriction both eyes. MRI brain: Lumbar puncture: Posterior flattening of Opening pressure 39 the globes cm H20 Empty sella Normal CSF studies otherwise normal Headache improved after LP IDIOPATHIC INTRACRANIAL HYPERTENSION SYNDROME: Increased intracranial pressure without ventriculomegaly or mass lesion Normal CSF composition NOMENCLATURE Idiopathic intracranial hypertension (IIH) Benign intracranial hypertension Pseudotumor cerebri Intracranial hypertension secondary to… DIAGNOSTIC CRITERIA Original criteria have been updated to reflect new imaging modalities: 1492 Friedman and Jacobsen. Neurology 2002; 59: Symptoms and signs reflect only those of - increased ICP or papilledema 1495 Documented increased ICP during LP in lateral decubitus position Normal CSF composition No evidence of mass, hydrocephalus, structural -
Sodium-Based Osmotherapy in Continuous Renal Replacement Therapy: a Mathematical Approach
Review Article Sodium-Based Osmotherapy in Continuous Renal Replacement Therapy: a Mathematical Approach Jerry Yee ,1 Naushaba Mohiuddin,2 Tudor Gradinariu,1 Junior Uduman,1 and Stanley Frinak1 Abstract Cerebral edema, in a variety of circumstances, may be accompanied by states of hyponatremia. The threat of brain injury from hypotonic stress-induced astrocyte demyelination is more common when vulnerable patients with hyponatremia who have end stage liver disease, traumatic brain injury, heart failure, or other conditions undergo overly rapid correction of hyponatremia. These scenarios, in the context of declining urinary output from CKD and/or AKI, may require controlled elevations of plasma tonicity vis-a`-vis increases of the plasma sodium concentration. We offer a strategic solution to this problem via sodium-based osmotherapy applied through a conventional continuous RRT modality: predilution continuous venovenous hemofiltration. KIDNEY360 1: 281–291, 2020. doi: https://doi.org/10.34067/KID.0000382019 Introduction continuous venovenous hemofiltration (CVVH) (11,12), Generally, sodium-based osmotherapy (SBO) is tonicity continuous venovenous hemodialysis (13), or con- therapy with the aim of reducing cerebral edema during tinuous venovenous hemodiafiltration (14). states of hypotonic hyponatremia. Depending on the circumstance, plasma tonicity may be increased or decreased. Because the sodium concentration ([Na]) General Principles of SBO in the plasma at any time (t), PNa(t), and accompa- SBO can be implemented as a stepwise approach nying anions constitute the bulk of plasma tonicity, based on established biophysical principles govern- SBOispredicatedongradualalterationofPNa,in ing sodium transit via predilution CVVH. The follow- contrast to the relatively rapid PNa increases imposed ing urea- and sodium-based kinetic methodology by steep dialysate-to-plasma [Na] gradients associ- involves six steps: (1) establishing a time-dependent ∇ ated with conventional hemodialysis. -
Spinal Cerebrospinal Fluid Leak
Spinal Cerebrospinal Fluid Leak –An Under-recognized Cause of Headache More common than expected, why is this type of headache so often misdiagnosed or the diagnosis is delayed? Challenging the “One Size Fits All” Approach in Modern Medicine As research becomes more patient-centric, it is time to recognize individual variations in response to treatment and determine why these differences occur. Newly Approved CGRP Blocker, Aimovig™, the First Ever Migraine- Specific Preventive Medicine The approval of erenumab and eventually, other drugs in this class heralds a new dawn for migraine therapy. But will it be accessible for patients who could respond to it? Remembering Donald J. Dalessio, MD $6.99 Volume 7, Issue 1 •2018 The Headache Clinic www.headaches.org Featuring the Baylor Scott & White Headache Clinic in Temple, Texas. An Excerpt from the New Book – Headache Solutions at the Diamond Headache Clinic Written by Doctor Diamond in collaboration with Brad Torphy, MD. Spinal Cerebrospinal Fluid Leak – An Under-recognized Cause of Headache Connie Deline, MD, Spinal CSF Leak Foundation Spontaneous intracranial hypotension, or low cerebrospinal fluid (CSF) pressure inside the head, is an under-recognized cause of headache that is treatable and in many cases, curable. Although misdiagnosis and delayed diagnosis remain common, increasing awareness of this condition is improving the situation for those afflicted. Frequently, patients with a confirmed diagnosis of intracranial hypotension will report that they have been treated for chronic migraine or another headache disorder for months or years. This type of headache rarely responds to medications; however, when treatment is directed at the appropriate underlying cause, most patients respond well. -
Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood- Brain Barrier Disruption After Experimental Stroke in Mice
RESEARCH ARTICLE Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood- Brain Barrier Disruption after Experimental Stroke in Mice Emil Zeynalov1*, Susan M. Jones1, Jeong-Woo Seo1, Lawrence D. Snell2, J. Paul Elliott3 1 Swedish Medical Center, Neurotrauma Research, Englewood, Colorado, United States of America, 2 Colorado Neurological Institute, Englewood, Colorado, United States of America, 3 Colorado Brain and Spine Institute, Englewood, Colorado, United States of America a11111 * [email protected] Abstract OPEN ACCESS Background Citation: Zeynalov E, Jones SM, Seo J-W, Snell LD, Stroke is a major cause of morbidity and mortality. Stroke is complicated by brain edema Elliott JP (2015) Arginine-Vasopressin Receptor and blood-brain barrier (BBB) disruption, and is often accompanied by increased release of Blocker Conivaptan Reduces Brain Edema and arginine-vasopressin (AVP). AVP acts through V1a and V2 receptors to trigger hyponatre- Blood-Brain Barrier Disruption after Experimental Stroke in Mice. PLoS ONE 10(8): e0136121. mia, vasospasm, and platelet aggregation which can exacerbate brain edema. The AVP doi:10.1371/journal.pone.0136121 receptor blockers conivaptan (V1a and V2) and tolvaptan (V2) are used to correct hypona- Editor: Muzamil Ahmad, Indian Institute of Integrative tremia, but their effect on post-ischemic brain edema and BBB disruption remains to be elu- Medicine, INDIA cidated. Therefore, we conducted this study to investigate if these drugs can prevent brain Received: May 25, 2015 edema and BBB disruption in mice after stroke. Accepted: July 29, 2015 Methods Published: August 14, 2015 Experimental mice underwent the filament model of middle cerebral artery occlusion Copyright: © 2015 Zeynalov et al. -
Case Report of Hyperacute Edema and Cavitation Following Deep Brain Stimulation Lead Implantation Albert J
www.surgicalneurologyint.com Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD, Clinical Professor of Neurological Surgery, School of Medicine, State U. of NY at Stony Brook. SNI: Stereotactic Editor Veronica Lok-Sea Chiang, MD Yale School of Medicine, New Haven, CT, USA Open Access Case Report Case report of hyperacute edema and cavitation following deep brain stimulation lead implantation Albert J. Fenoy1,2, Christopher R. Conner2, Joseph S. Withrow2, Aaron W. Hocher2 Movement Disorders and Neurodegenerative Disease Program, Departments of 1Neurology, 2Neurosurgery, McGovern Medical School, Houston, Texas, United States. E-mail: *Albert J. Fenoy - [email protected]; Christopher R. Conner - [email protected]; Joseph S. Withrow - joseph.s.withrow@ uth.tmc.edu; Aaron W. Hocher - [email protected] ABSTRACT Background: Postoperative cerebral edema around a deep brain stimulation (DBS) electrode is an uncommonly reported complication of DBS surgery. e etiology of this remains unknown, and the presentation is highly variable; however, the patients generally report a good outcome. Case Description: Here, we report an unusual presentation of postoperative edema in a 66-year-old female *Corresponding author: who has bilateral dentatorubrothalamic tract (specifically, the ventral intermediate nucleus) DBS for a mixed Albert J. Fenoy, type tremor disorder. Initial postoperative computed tomography (CT) was unremarkable and the patient was Department of Neurosurgery, admitted for observation. She declined later on postoperative day (POD) 1 and became lethargic. Stat head CT McGovern Medical School, scan performed revealed marked left-sided peri-lead edema extending into the centrum semiovale with cystic 6431 Fannin St., Houston, Texas cavitation, and trace right-sided edema. -
Cerebral Hemodynamics and Intracranial Compliance Impairment in Critically Ill COVID-19 Patients: a Pilot Study
brain sciences Article Cerebral Hemodynamics and Intracranial Compliance Impairment in Critically Ill COVID-19 Patients: A Pilot Study Sérgio Brasil 1,*, Fabio Silvio Taccone 2,Sâmia Yasin Wayhs 1, Bruno Martins Tomazini 3, Filippo Annoni 2, Sérgio Fonseca 3, Estevão Bassi 3, Bruno Lucena 3, Ricardo De Carvalho Nogueira 1, Marcelo De-Lima-Oliveira 1, Edson Bor-Seng-Shu 1, Wellingson Paiva 1 , Alexis Fournier Turgeon 4 , Manoel Jacobsen Teixeira 1 and Luiz Marcelo Sá Malbouisson 3 1 Division of Neurosurgery, Department of Neurology, Universidade de São Paulo, São Paulo 05403-000, Brazil; [email protected] (S.Y.W.); [email protected] (R.D.C.N.); [email protected] (M.D.-L.-O.); [email protected] (E.B.-S.-S.); [email protected] (W.P.); [email protected] (M.J.T.) 2 Department of Intensive Care, Universitè Libre de Bruxelles, 1000 Brussels, Belgium; [email protected] (F.S.T.); fi[email protected] (F.A.) 3 Department of Intensive Care, Universidade de São Paulo, São Paulo 05403-000, Brazil; [email protected] (B.M.T.); [email protected] (S.F.); [email protected] (E.B.); [email protected] (B.L.); [email protected] (L.M.S.M.) 4 Division of Critical Care Medicine and the Department of Anesthesiology, Université Laval, Québec City, QC G1V 0A6, Canada; [email protected] * Correspondence: [email protected] Abstract: Introduction: One of the possible mechanisms by which the new coronavirus (SARS- Citation: Brasil, S.; Taccone, F.S.; Cov2) could induce brain damage is the impairment of cerebrovascular hemodynamics (CVH) and Wayhs, S.Y.; Tomazini, B.M.; Annoni, intracranial compliance (ICC) due to the elevation of intracranial pressure (ICP). -
Critical Care and Resuscitation • Volume 11 Number 2 • June 2009 151 POINTS of VIEW
POINTS OF VIEW Mannitol or hypertonic saline for intracranial hypertension? A point of view Luis B Castillo, Guillermo A Bugedo and Jorge L Paranhos Osmotically active solutions have been used for more than ABSTRACT 30 years in the treatment of intracranial hypertension. The traditional agent of choice has been mannitol, but hyper- Osmotically active solutions, particularly mannitol, have tonicCrit saline Care has Resusc recently ISSN: emerged 1441-2772 as an1 Junealternative. Here, been used for more than 30 years in the treatment of we discuss2009 11 the2 151-154 systemic and cerebral effects of these two intracranial hypertension. Recently hypertonic saline has ©Crit Care Resusc 2009 substances,www.jficm.anzca.edu.au/aaccm/journal/publi- as well as their side effects and complications, emerged as an alternative to mannitol. Both solutions are and cations.htmmake recommendations about their clinical use. used worldwide, and their indications and long-term side Points of View effects are well known. More recently, knowledge about their effects has increased, both limiting and expanding Mannitol their clinical use. Here, we compare the systemic and Mannitol has been the agent of choice in osmotherapy for cerebral effects of mannitol and hypertonic saline, as well as cerebral injury since the 1960s. It is a mannose-derived their side effects and complications. Finally, we make simple alcohol, which is easy to prepare and use, stable in recommendations about their clinical use. solution, inert, not metabolised, freely filtered by the kidneys without being reabsorbed, and low in toxicity. Its Crit Care Resusc 2009; 11: 151–154 distribution volume corresponds to the extracellular com- partment.1-7 The effects of mannitol on the central nervous For editorial comment, see page 94 system have been well described, but the mechanisms are still not completely understood. -
Suarez, JI: Hypertonic Saline for Cerebral Edema
Hypertonic saline for cerebral edema and elevated intracranial pressure JOSE´ I. SUAREZ, MD erebral edema and elevated intracranial movements. Because transport through the BBB is a pressure (ICP) are important and frequent selective process, the osmotic gradient that a particle problems in the neurocritically ill patient. can create is also dependent on how restricted its They can both result from various insults permeability through the barrier is. This restriction is C expressed in the osmotic reflection coefficient, which to the brain. Improving cerebral edema and decreas- ing ICP has been associated with improved out- ranges from 0 (for particles that can diffuse freely) to come.1 However, all current treatment modalities 1.0 (for particles that are excluded the most effec- are far from perfect and are associated with serious tively and therefore are osmotically the most active). adverse events:1–4 indiscriminate hyperventilation The reflection coefficient for sodium chloride is can lead to brain ischemia; mannitol can cause 1.0 (mannitol’s is 0.9), and under normal conditions intravascular volume depletion, renal insufficiency, sodium (Na+) has to be transported actively into the and rebound ICP elevation; barbiturates are associat- CSF.5,6 Animal studies have shown that in condi- ed with cardiovascular and respiratory depression tions of an intact BBB, CSF Na+ concentrations and prolonged coma; and cerebrospinal fluid (CSF) increase when an osmotic gradient exists but lag drainage via intraventricular catheter insertion may behind plasma concentrations for 1 to 4 hours.5 result in intracranial bleeding and infection. Thus, elevations in serum Na+ will create an effec- Other treatment modalities have been explored, tive osmotic gradient and draw water from brain into and hypertonic saline (HS) solutions particularly the intravascular space. -
Neurologic Complications of Electrolyte Disturbances and Acid–Base Balance
Handbook of Clinical Neurology, Vol. 119 (3rd series) Neurologic Aspects of Systemic Disease Part I Jose Biller and Jose M. Ferro, Editors © 2014 Elsevier B.V. All rights reserved Chapter 23 Neurologic complications of electrolyte disturbances and acid–base balance ALBERTO J. ESPAY* James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, UC Neuroscience Institute, University of Cincinnati, Cincinnati, OH, USA INTRODUCTION hyperglycemia or mannitol intake, when plasma osmolal- ity is high (hypertonic) due to the presence of either of The complex interplay between respiratory and renal these osmotically active substances (Weisberg, 1989; function is at the center of the electrolytic and acid-based Lippi and Aloe, 2010). True or hypotonic hyponatremia environment in which the central and peripheral nervous is always due to a relative excess of water compared to systems function. Neurological manifestations are sodium, and can occur in the setting of hypovolemia, accompaniments of all electrolytic and acid–base distur- euvolemia, and hypervolemia (Table 23.2), invariably bances once certain thresholds are reached (Riggs, reflecting an abnormal relationship between water and 2002). This chapter reviews the major changes resulting sodium, whereby the former is retained at a rate faster alterations in the plasma concentration of sodium, from than the latter (Milionis et al., 2002). Homeostatic mech- potassium, calcium, magnesium, and phosphorus as well anisms protecting against changes in volume and sodium as from acidemia and alkalemia (Table 23.1). concentration include sympathetic activity, the renin– angiotensin–aldosterone system, which cause resorption HYPONATREMIA of sodium by the kidneys, and the hypothalamic arginine vasopressin, also known as antidiuretic hormone (ADH), History and terminology which prompts resorption of water (Eiskjaer et al., 1991).